- Home
- OLMA vs FINS Comparison
OLMA vs FINS Comparison
Compare OLMA & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OLMA | FINS |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 439.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OLMA | FINS |
|---|---|---|
| Price | $26.39 | $13.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $40.50 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 78.0K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $11.61 |
| 52 Week High | $36.26 | $12.57 |
Technical Indicators
Market Signals| Indicator | OLMA | FINS |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 49.60 |
| Support Level | $25.85 | $12.91 |
| Resistance Level | $36.26 | $13.22 |
| Average True Range (ATR) | 2.77 | 0.15 |
| MACD | -1.22 | 0.00 |
| Stochastic Oscillator | 6.25 | 52.78 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.